Publicacións nas que colabora con Roberto Méndez Gallart (1)

2022

  1. Case Report: Everolimus reduced bone turnover markers but showed no clinical benefit in a patient with severe progressive osseous heteroplasia

    Frontiers in Pediatrics, Vol. 10